Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosalt Regulatory News (SALT)

Share Price Information for Microsalt (SALT)

Share Price is delayed by 15 minutes
Get Live Data
36.50    0.00 (0.00%)
Bid:
35.00
Ask:
38.00
Spread: 3.00 (8.571%)
Market Cap: £20.49m
SALT Live PriceLast checked at - London Stock Exchange

Intraday Microsalt Share Chart

New Strategic Relationship with Daiya Foods

12 Nov 2025 07:00

RNS Number : 1352H
MicroSalt PLC
12 November 2025
 

 

 

 

 

 

 

12 November 2025

 

MicroSalt plc

("MicroSalt" or the "Company")

 

New Strategic Relationship with Daiya Foods

 

MicroSalt announces a new strategic relationship with Daiya Foods, a leader in dairy-free and plant-based innovation foods.

 

MicroSalt plc (AIM: SALT), a leading manufacturer of full-flavour natural salt with approximately 50% less sodium, is pleased to announce a new relationship with Daiya Foods Inc. ("Daiya Foods"), a global leader in dairy-free and plant-based food innovation. MicroSalt has received an initial order of $50k to begin production and its projected 2026 volume to approximate $500k.

 

Acquired by Otsuka Pharmaceutical Co., Ltd in 2017 for $405 million, Daiya Foods is recognised for pioneering dairy-free products that deliver the taste, texture, and nutritional satisfaction consumers expect from traditional dairy foods. Available in 25,000 grocery stores in the US and Canada, as well as through e-commerce partnerships, Daiya Foods' products can be found internationally in Asia, Europe, and Latin America.

 

MicroSalt expects to be integrated into the Daiya Foods portfolio of product lines, with an initial focus on cheese and pizza dough, supporting Daiya Foods' mission to provide delicious, accessible, and healthier plant-based alternatives. The collaboration represents an important step in expanding MicroSalt's reach beyond the snack sector into broader food applications where sodium reduction has traditionally challenged flavour and functionality.

 

This collaboration further reinforces MicroSalt's position as a preferred partner for global food manufacturers seeking to meet consumer demand for healthier, full-flavour products. As the drive toward sodium reduction accelerates across international markets, MicroSalt continues to expand its footprint across multiple categories, from snacks and condiments to frozen meals and dairy alternatives, enabling brands to achieve meaningful sodium reduction without compromise on taste or texture.

 

Rick Guiney, CEO of MicroSalt, commented:

 

"We're very pleased to align efforts with Daiya Foods, a company that shares our vision of making healthier eating both delicious and accessible. This collaboration demonstrates the versatility of MicroSalt's technology across diverse food categories-from dairy-free alternatives to frozen meals and sauces. It's another step in our journey to make sodium reduction a standard part of holistic, better-for-you reformulation across the food industry."

 

Enquiries:

 

MicroSalt plc

c/o +44 (0)20 4582 3500

Rick Guiney, CEO 

Zeus (Nominated adviser and broker)

+44 (0)20 3829 5000

David Foreman, James Edis (Investment Banking)

Gracechurch Group (Financial PR)  

+44 (0)20 4582 3500

Heather Armstrong, Alexis Gore, Rebecca Scott

 

About MicroSalt 

 

MicroSalt is disrupting the global salt market with its patented, full-flavour, low-sodium salt designed for both food manufacturers and consumers. Using proprietary micron-sized particles, MicroSalt® delivers the same salty taste as traditional salt with approximately 50% less sodium, offering a scalable solution to one of the world's most pressing health challenges. Year to date through 2025, MicroSalt® has contributed to more than 634M servings made healthier.

 

Excess sodium consumption is a leading contributor to cardiovascular disease, the world's number one cause of death. The World Health Organisation has targeted a 30% reduction in global sodium intake by 2025, a shift projected to save seven million lives by 2030. The economic case is equally compelling: in the UK alone, cardiovascular disease costs £19 billion annually, and reducing average daily salt intake by just one gram could save over 4,000 lives and £288 million each year. 

 

Operational since 2018, MicroSalt has established a defensible IP portfolio, holding a granted US patent and 14 pending applications worldwide. These protections create significant barriers to entry in a market expected to grow exponentially as regulation and consumer demand accelerate.

 

MicroSalt is ideally positioned for scale and market leadership, with clear pathways into food manufacturing, consumer channels, and ultimately the broader £10+ billion global salt market. MicroSalt is more than a healthier alternative-it is a disruptive, category-defining solution poised to deliver significant commercial and societal impact.

 

For more information, please visit www.microsaltinc.co or follow on X @microSaltPLC.

 

About Daiya Foods Inc.

 

Daiya Foods Inc. is a pioneering Canadian food company committed to creating plant-based comfort foods for everyone. Founded in 2008 and headquartered in Burnaby, British Columbia, Daiya has grown from its origins in dairy-free cheese alternatives to a broad portfolio of dairy-free pizzas, mac & cheese, desserts and more. The Company's products are allergen-friendly (free of dairy, soy, gluten and nuts in many cases), non-GMO certified, and designed to deliver the taste, texture and melt of conventional comfort foods - without compromise.

 

Backed by global parent Otsuka Pharmaceutical Co., Ltd., Daiya is committed to innovation, sustainability and inclusivity. From its LEED-certified production facility in British Columbia to its mission of "cheese reimagined" for all, Daiya is leading the charge in the plant-based movement.

 

To learn more, visit www.daiyafoods.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRBDBXXBDGUB
12
Date   Source Headline
5th Jun 20267:00 amRNSNotice of AGM
28th May 20267:07 amRNSFinal Results
28th Apr 20267:00 amRNS-RMicroSalt Launches MicroSalt Fibre
5th Mar 20267:00 amRNS-RNew UK customer
2nd Mar 20267:00 amRNS-RMicroSalt Reaches One Billion Servings Milestone
13th Feb 20267:00 amRNSGrant of options and PDMR dealings
27th Jan 20267:25 amRNSSigned Joint Development Agreement
12th Jan 20267:00 amRNSTrading Update
15th Dec 20252:17 pmRNSAdmission, Director Dealings and TVR
12th Dec 20252:30 pmRNSResult of Retail Offer
9th Dec 20254:35 pmRNSLaunch of Retail Offer
9th Dec 20252:40 pmRNSSubscription to raise £1.5 million
21st Nov 20253:38 pmRNSExercise of Stock Options and Total Voting Rights
14th Nov 20257:00 amRNSTrading Update
12th Nov 20257:00 amRNSNew Strategic Relationship with Daiya Foods
30th Sep 20257:00 amRNSUnaudited Half-yearly Report
1st Sep 20257:00 amRNSBoard changes
18th Aug 20257:00 amRNSH1 2025 Trading Update
11th Aug 20257:00 amRNSMissed related party transaction
6th Aug 20257:38 amRNSRelated Party Transaction
27th Jun 20253:48 pmRNSResult of AGM
6th Jun 202512:30 pmRNSHolding(s) in Company
2nd Jun 20257:01 amRNSNotice of Investor Presentation 9th June 2025
2nd Jun 20257:00 amRNSFinal Results Year Ended 31 December Notice of AGM
24th Apr 20257:00 amRNSQ1 2025 Business Update
24th Mar 20257:00 amRNS-RIFE London Innovation in Nutritious Foods
19th Mar 20257:00 amRNS-RFast Award 2025
25th Feb 20257:00 amRNS-RTechnology of the Year 2025 Award
14th Feb 20251:22 pmRNSNotification of Major Holdings
14th Feb 20251:06 pmRNSNotification of Major Holdings
7th Feb 20257:00 amRNSFurther Re Fundraising
5th Feb 20257:00 amRNSExercise of Stock Options and Total Voting Rights
3rd Feb 20257:00 amRNSOversubscribed Fundraising of £2.3Million
16th Jan 20257:00 amRNS-RFDA Nutrition information on packaged foods
6th Jan 20254:51 pmRNSResults of General Meeting
10th Dec 20247:00 amRNSShareholder Circular and Notice of General Meeting
30th Oct 20247:00 amRNSNew and Follow-on B2B Customer Orders
18th Oct 20247:00 amRNSResponse to Share Price Movement
27th Sep 20247:00 amRNSMaiden Interim Results
16th Sep 20247:00 amRNSMultiple Placements of Products and B2B Progress
2nd Aug 20243:02 pmRNSNotification of Major Holdings
30th Jul 20247:00 amRNSExercise of Warrants and Total Voting Rights
16th Jul 20247:00 amRNSExercise Warrants PDMR Dealing Total Voting Rights
11th Jul 20247:00 amRNSExercise of Warrants and Total Voting Rights
2nd Jul 20243:31 pmRNSExercise of Warrants and Total Voting Rights
21st Jun 20243:17 pmRNSResult of AGM
17th Jun 202411:22 amRNSExercise Warrants PDMR Dealing Total Voting Rights
11th Jun 20247:00 amRNSExercise Warrants Options and Total Voting Rights
30th May 20247:20 amRNSFinal Year end Results and Notice of AGM
24th May 20244:18 pmRNSExercise of Warrants
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.